A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension.

Managed care interface

Volumn 14, Issue 3, 2001, Pages 82-87

  Doyle, J ^a   Omvik, P ^a   Arikian, S ^a   Casciano, J ^a   Casciano, R ^a   Gonzalez, M A ^a   Arocho, R ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ENALAPRIL;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG COMBINATION; DRUG COST; ECONOMICS; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED STATES;

AMLODIPINE; ANTIHYPERTENSIVE AGENTS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DRUG COSTS; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 0035294437     PISSN: 10965645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)